UPDATE: Proteostasis Therapeutics (PTI) PT Raised to $8 at Leerink Partners Citing Encouraging FEV1 Functional Data & Clean Safety Profile
Tweet Send to a Friend
(Updated - December 12, 2017 11:42 AM EST)(updated to add analyst comment)Leerink Partners raised its price target on Proteostasis Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
